Hmga2 is dispensable for pancreatic cancer development metastasis and therapy resistance
Bioportfolio,
| NEJM Related Biotechnology, Pharmaceutical and Healthcare News Original Article: Hmga2 is dispensable for pancreatic cancer…
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Overview of attention for article published in Scientific Reports, September 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (81st percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Readers on
- mendeley
- 16 Mendeley